Iopamidol Injection, Solution
Product Images NDC 70436-211

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Iopamidol (NDC 70436-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of iopamidol, showing its iodine atoms attached to a benzene ring with multiple hydroxyl and amide groups linked to the ring.*

FDA Label Image

Vial-50 mL (Image 02)

Label for iopamidol Injection, USP 20% (408 mg/mL) solution for intravascular use only, in a 50 mL single-dose vial. The label includes warnings against intrathecal use, storage instructions at 20° to 25°C, and information on the manufacturer and distributor: Slate Run Pharmaceuticals, LLC. The label also highlights a 41% concentration of organically bound iodine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.